An update on methods for detection of prognostic and predictive biomarkers in melanoma

The approval of immunotherapy for stage II-IV melanoma has underscored the need for improved immune-based predictive and prognostic biomarkers. For resectable stage II-III patients, adjuvant immunotherapy has proven clinical benefit, yet many patients experience significant adverse events and may no...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeuyan, Oluwaseyi, Gordon, Emily R., Kenchappa, Divya, Bracero, Yadriel, Singh, Ajay, Espinoza, Gerardo, Geskin, Larisa J., Saenger, Yvonne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611507/
https://www.ncbi.nlm.nih.gov/pubmed/37900283
http://dx.doi.org/10.3389/fcell.2023.1290696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611507/
https://www.ncbi.nlm.nih.gov/pubmed/37900283
http://dx.doi.org/10.3389/fcell.2023.1290696

Ejemplares similares